2012 highlights in translational 'omics

Genome Medicine

Volumn 5, Issue 1, 2013, Pages

  Auffray, Charles ^a   Caulfield, Timothy ^b   Khoury, Muin J ^c   Lupski, James R ^d,e   Schwab, Matthias ^f,g   Veenstra, Timothy ^h  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e TEXAS CHILDREN S HOSPITAL   (United States)

^f DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^g UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^h NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; BIOMICS; BREAST CANCER; CEREBROVASCULAR ACCIDENT; CHLORIDE TRANSPORT; CHROMOSOME 18; DNA DETERMINATION; EDITORIAL; EPIGENETICS; EXOME; GENE MUTATION; GENE SEQUENCE; GENOMICS; HEALTH CARE POLICY; HEART INFARCTION; HUMAN; INHERITANCE; MASS SPECTROMETRY; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY CANCER; PATIENT CARE; PHARMACOGENOMICS; PRIORITY JOURNAL; PROGENY; PROTEOMICS; PUBLIC HEALTH; SACCHAROMYCES CEREVISIAE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS;

EID: 84873047322     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm414     Document Type: Editorial

References (41)

1. Albers CA, Paul DS, Schulze H, Freson K, Stephens JC, Smethurst PA, Jolley JD, Cvejic A, Kostadima M, Bertone P, Breuning MH, Debili N, Deloukas P, Favier R, Fiedler J, Hobbs CM, Huang N, Hurles ME, Kiddle G, Krapels I, Nurden P, Ruivenkamp CA, Sambrook JG, Smith K, Stemple DL, Strauss G, Thys C, van Geet C, Newbury-Ecob R, Ouwehand WH, Ghevaert C. Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet 2012, 44:435-9. S1-S2, 10.1038/ng.1083, 3428915, 22366785.
2. Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, Amell AM, van der Vliet PJ, Almomani R, Straasheijm KR, Krom YD, Klooster R, Sun Y, Den Dunnen JT, Helmer Q, Donlin-Smith CM, Padberg GW, van Engelen BG, de Greef JC, Aartsma-Rus AM, Frants RR, de Visser M, Desnuelle C, Sacconi S, Filippova GN, Bakker B, Bamshad MJ, Tapscott SJ, Miller DG, van der Maarel SM. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 2012, 44:1370-1374. 10.1038/ng.2454, 23143600.
3. Lupski JR. Digenic inheritance and Mendelian disease. Nat Genet 2012, 44:1291-1292. 10.1038/ng.2479, 23192179.
4. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, Gudjonsson SA, Sigurdsson A, Jonasdottir A, Jonasdottir A, Wong WS, Sigurdsson G, Walters GB, Steinberg S, Helgason H, Thorleifsson G, Gudbjartsson DF, Helgason A, Magnusson OT, Thorsteinsdottir U, Stefansson K. Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012, 488:471-475. 10.1038/nature11396, 22914163.
5. Sun Z, Liu P, Jia X, Withers MA, Jin L, Lupski JR, Zhang F. Replicative mechanisms of CNV formation preferentially occur as intrachromosomal events: evidence from Potocki-Lupski duplication syndrome. Hum Mol Genet 2012, doi: 10.1093/hmg/dds482.
6. Campbell CD, Chong JX, Malig M, Ko A, Dumont BL, Han L, Vives L, O'Roak BJ, Sudmant PH, Shendure J, Abney M, Ober C, Eichler EE. Estimating the human mutation rate using autozygosity in a founder population. Nat Genet 2012, 44:1277-1281. 10.1038/ng.2418, 23001126.
7. Hurles M. Older males beget more mutations. Nat Genet 2012, 44:1174-1176. 10.1038/ng.2448, 23104062.
8. Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B, Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J, Joset P, Röpke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E, Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012, 380:1674-1682. 10.1016/S0140-6736(12)61480-9, 23020937.
9. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012, 367:1921-1929. 10.1056/NEJMoa1206524, 23033978.
10. Office of Public Health Genomics, Centers for Disease Control and Prevention. , http://www.cdc.gov/genomics/
11. PHG Foundation: Translating genomics: making science work for health. , http://www.phgfoundation.org/15years/
12. Public Health Genomics European Network. , http://www.phgen.eu/typo3/index.php
13. Burke W, Burton H, Hall AE, Karmali M, Khoury MJ, Knoppers B, Meslin EM, Stanley F, Wright CF, Zimmern RL. Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and 'personalized' medicine?. Genet Med 2010, 12:785-791. 10.1097/GIM.0b013e3182011222, 21189494.
14. Walker MJ, Beatson SA. Epidemiology. Outsmarting outbreaks. Science 2012, 338:1161-1162. 10.1126/science.1232327, 23197523.
15. Flintoft L. Translational genetics: whole-genome sequencing diagnostics for newborns. Nat Rev Genet 2012, 13:758.
16. Centers for Disease Control and Prevention Genomic Tests and Family History by Levels of Evidence Centers for Disease Control and Prevention., http://www.cdc.gov/genomics/gtesting/tier.htm
17. Bowen MS, Kolor K, Dotson WD, Ned RM, Khoury MJ. Public Health Action in Genomics Is Now Needed beyond Newborn Screening. Public Health Genomics 2012, 15:327-334. 10.1159/000341889, 22986915.
18. Collins FS. Shattuck lecture--medical and societal consequences of the Human Genome Project. N Engl J Med 1999, 341:28-37. 10.1056/NEJM199907013410106, 10387940.
19. PharmGKB: IL28B. , http://www.pharmgkb.org/gene/PA134952671
20. Heim MH. Innate immunity and HCV. J Hepatol 2012, doi: 10.1016/j.jhep.2012.10.005.
21. Barrett PM, Alagely A, Topol EJ. Cystic fibrosis in an era of genomically guided therapy. Hum Mol Genet 2012, 21:R66-R71. 10.1093/hmg/dds345, 22914736.
22. Meyer UA, Zanger UM, Schwab M. Omics and drug response. Annu Rev Pharmacol Toxicol 2013, 53:475-502. 10.1146/annurev-pharmtox-010510-100502, 23140244.
23. Schwab M, Schaeffeler E. Pharmacogenomics: a key component of personalized therapy. Genome Med 2012, 4:93. 10.1186/gm394, 23194652.
24. Kellie JF, Catherman AD, Durbin KR, Tran JC, Tipton JD, Norris JL, Witkowski CE, Thomas PM, Kelleher NL. Robust analysis of the yeast proteome under 50 kDa by molecular-mass-based fractionation and top-down mass spectrometry. Anal Chem 2012, 84:209-215. 10.1021/ac202384v, 3262231, 22103811.
25. Tran JC, Zamdborg L, Ahlf DR, Lee JE, Catherman AD, Durbin KR, Tipton JD, Vellaichamy A, Kellie JF, Li M, Wu C, Sweet SM, Early BP, Siuti N, LeDuc RD, Compton PD, Thomas PM, Kelleher NL. Mapping intact protein isoforms in discovery mode using top-down proteomics. Nature 2011, 480:254-258. 10.1038/nature10575, 3237778, 22037311.
26. Hood L, Balling R, Auffray C. Revolutionizing medicine in the 21st century through systems approaches. Biotechnol J 2012, 7:992-1001. 10.1002/biot.201100306, 22815171.
27. Fugger L, McVean G, Bell JI. Genomewide association studies and common disease--realizing clinical utility. N Engl J Med 2012, 367:2370-2371. 10.1056/NEJMp1212285, 23252523.
28. Poste G. Bring on the biomarkers. Nature 2011, 469:156-157. 10.1038/469156a, 21228852.
29. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, Miriami E, Karczewski KJ, Hariharan M, Dewey FE, Cheng Y, Clark MJ, Im H, Habegger L, Balasubramanian S, O'Huallachain M, Dudley JT, Hillenmeyer S, Haraksingh R, Sharon D, Euskirchen G, Lacroute P, Bettinger K, Boyle AP, Kasowski M, Grubert F, Seki S, Garcia M, Whirl-Carrillo M, Gallardo M, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012, 148:1293-1307. 10.1016/j.cell.2012.02.009, 22424236.
30. Smarr L. Quantifying your body: a how-to guide from a systems biology perspective. Biotechnol J 2012, 7:980-991. 10.1002/biot.201100495, 22887886.
31. Agusti A, Macnee W. The COPD control panel: towards personalised medicine in COPD. Thorax 2012, doi:10.1136/thoraxjnl-2012-202772.
32. Auffray C, Hood L. Editorial: Systems biology and personalized medicine - the future is now. Biotechnol J 2012, 7:938-939. 10.1002/biot.201200242, 22887882.
33. Talkowski ME, Ordulu Z, Pillalamarri V, Benson CB, Blumenthal I, Connolly S, Hanscom C, Hussain N, Pereira S, Picker J, Rosenfeld JA, Shaffer LG, Wilkins-Haug LE, Gusella JF, Morton CC. Clinical diagnosis by whole-genome sequencing of a prenatal sample. N Engl J Med 2012, 367:2226-2232. 10.1056/NEJMoa1208594, 23215558.
34. Evans JP, Berg JS. Next-generation DNA sequencing, regulation, and the limits of paternalism: the next challenge. JAMA 2011, 306:2376-2377. 10.1001/jama.2011.1788, 22147382.
35. Rochman B. Why Cheaper Genetic Testing Could Cost Us a Fortune. Time 2012, , http://healthland.time.com/2012/10/26/why-cheaper-genetic-testing-could-cost-us-a-fortune/
36. PHG Foundation Whole Genome Sequencing: Clinical Impact and Implications for Health Care 2011, PHG Foundation., http://www.phgfoundation.org/file/10365/
37. Gutmann A. Privacy and whole genome sequencing. Reuters 2012, , http://blogs.reuters.com/great-debate/2012/10/11/privacy-and-whole-genome-sequencing/
38. Presidential Commission for the Study of Bioethical Issues Privacy and Progress in Whole Genome Sequencing. 2012, Presidential Commission for the Study of Bioethical Issues., http://www.bioethics.gov/cms/node/764
39. King JS. Genetic tests: Politics and fetal diagnostics collide. Nature 2012, 491:3334.
40. The Editors World Changing Ideas 2012. Sci Am 2012, The Editors., http://www.scientificamerican.com/article.cfm?id=world-changing-ideas-2012-innovations-radical-enough-alter-lives
41. The American College of Obstetricians and Gynecologists Committee on Genetics and The Society for Maternal-Fetal Medicine Publications Committee. Noninvasive Prenatal Testing for Fetal Aneuploidy: Committee Opinion. Number 545, December 2012 [http://www.acog.org/Resources_And_Publications/Committee_Opinions/Committee_on_Genetics/Noninvasive_Prenatal_Testing_for_Fetal_Aneuploidy.